Category : Clinical Research, Pharma & Healthcare Financing

Clinical Research, Pharma & Healthcare Financing

PatchMD Launches Mito Cocktail Patch for ASD Mitochondrial Health

GlobeNewswire
by GlobeNewswire0177
PatchMD, a leader in innovative nutrient delivery systems, proudly announces the launch of its new Mito Cocktail Patch, designed to support mitochondrial function for individuals with...
Clinical Research, Pharma & Healthcare Financing

IFF Pharma Solutions Unveils Next-Gen Excipient Innovations

Business Wire
by Business Wire0179
Global Leading Excipient Supplier to Highlight Innovations in Oral Disintegrating Tablets, Controlled Release Formulations, and Low-Nitrite Solutions IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge...
Clinical Research, Pharma & Healthcare Financing

Scienture Draws on ELOC, Suspends Further Draws for 30 Days

GlobeNewswire
by GlobeNewswire0314
SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing,...
Clinical Research, Pharma & Healthcare Financing

Alvotech Acquires Xbrane’s R&D Operations, Strengthening Biosimilars

GlobeNewswire
by GlobeNewswire0254
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the acquisition of Xbrane...
Clinical Research, Pharma & Healthcare Financing

Virpax Announces Positive Probudur™ Dose Range Study Results

Business Wire
by Business Wire0240
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system...
Clinical Research, Pharma & Healthcare Financing

Humanetics Chooses Lifecore for BIO 300 CDMO Services

GlobeNewswire
by GlobeNewswire0170
Humanetics’ Novel Radioprotective Agent Being Developed with Funding from Department of Defense as Radiation Medical Countermeasure (MCM) Lifecore to Carry Out Tech Transfer and Analytical...
Clinical Research, Pharma & Healthcare Financing

RedHill Biopharma to Submit Talicia® for UK Approval

PR Newswire
by PR Newswire0169
RedHill plans to submit UK MAA1 for Talicia for H. pylori infection, using MHRA’s2 new fast-track approval process, referencing FDA approval, with potential UK approval in Q4/25 Listed...